Tekla Capital Management’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $92K | Hold |
|
|||||
|
2019
Q3 | $116K | Sell |
|
|||||
|
2019
Q2 | $919K | Hold |
|
|||||
|
2019
Q1 | $983K | Hold |
|
|||||
|
2018
Q4 | $1.31M | Sell |
|
|||||
|
2018
Q3 | $4.77M | Sell |
|
|||||
|
2018
Q2 | $10.2M | Hold |
|
|||||
|
2018
Q1 | $9.61M | Sell |
|
|||||
|
2017
Q4 | $6.25M | Hold |
|
|||||
|
2017
Q3 | $7.66M | Sell |
|
|||||
|
2017
Q2 | $6.58M | Hold |
|
|||||
|
2017
Q1 | $8.08M | Buy |
|
|||||
|
2016
Q4 | $2.29M | Hold |
|
|||||
|
2016
Q3 | $3.99M | Buy |
|
|||||
|
2016
Q2 | $2.42M | Hold |
|
|||||
|
2016
Q1 | $2.41M | Hold |
|
|||||
|
2015
Q4 | $3.58M | Buy |
|
|||||
|
2015
Q3 | $3.38M | Buy |
|
|||||
|
2015
Q2 | $504K | Buy |
|